Chemed Corporation reports developments across two wholly owned subsidiaries: VITAS Healthcare, a provider of hospice and palliative end-of-life care, and Roto-Rooter, which provides plumbing, drain cleaning, water restoration and related services to residential and commercial customers.
Company news commonly covers quarterly operating results, VITAS patient revenue, admissions and census measures, Roto-Rooter service demand, franchise territory acquisitions, credit facility updates, share repurchases, new hospice-care locations and investor conference presentations.
Chemed Corporation (NYSE:CHE) has declared a quarterly cash dividend of 38-cents per share, to be paid on March 17, 2023, to shareholders on record as of February 27, 2023. This dividend matches the amount paid in December 2022 and marks the company's 207th consecutive quarterly dividend in its 50 years as a public entity. Chemed Corporation operates two subsidiaries: VITAS Healthcare, the largest provider of hospice care, and Roto-Rooter, a leading plumbing services company.
Chemed Corporation (NYSE: CHE) has announced that it will release its financial results for the fourth quarter ended December 31, 2022, on February 23, 2023, post-market close. A conference call will be held on February 24, 2023, at 10 a.m. ET to discuss the quarterly results and provide a business update. Investors can access the conference call via the investor relations section of Chemed's website. Chemed operates VITAS Healthcare, the largest provider of end-of-life hospice care, and Roto-Rooter, the leading plumbing and drain cleaning service provider in the nation.
Chemed Corporation (NYSE:CHE) will present at the BofA Securities 2022 Virtual Home Care Conference on Tuesday, December 5, 2022, at 10:40 AM ET. The live presentation will be webcast and accessible through the Chemed website, with a replay available within 24 hours for 90 days. Chemed operates VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, the leading plumbing service. Investors should note that statements made during the presentation may contain forward-looking information, subject to risks and uncertainties.
Chemed Corporation (NYSE:CHE) has declared a quarterly cash dividend of 38-cents per share, payable on December 5, 2022, to shareholders of record as of November 14, 2022. This dividend is consistent with that paid in September 2022 and marks the 206th consecutive quarterly dividend in the company's history as a public entity spanning 51 years. Chemed operates two key subsidiaries: VITAS Healthcare and Roto-Rooter.
Chemed Corporation (NYSE: CHE) reported a 2.3% decline in revenue to $526 million in Q3 2022, with GAAP EPS at $3.78. Adjusted diluted EPS decreased by 6.3% to $4.74. The VITAS segment saw a 6.6% drop in net patient revenue to $297 million, with significant declines in admissions (16.6%) and average daily census (4.4%). Conversely, Roto-Rooter revenue rose 3.9% to $230 million, while adjusted EBITDA increased 5.7% to $69.5 million. Cash and equivalents stood at $7.8 million, with $101 million in debt. Share repurchases totaled 50,000 shares for $23.9 million.
Chemed Corporation (NYSE:CHE) announced its upcoming presentation at the 31st Annual Credit Suisse Healthcare Conference on November 9, 2022, at 2:00 p.m. (PST). The event will take place at The Terranea Resort in Rancho Palos Verdes, CA, and will be available via live webcast on the Chemed website. A replay will be accessible for 90 days. Chemed operates two main subsidiaries: VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, a leading plumbing service provider.
Chemed Corporation (NYSE: CHE) will release its third-quarter financial results for the period ending September 30, 2022, on October 31, 2022, after market close. A conference call to discuss these results will take place on November 1, 2022, at 10 a.m. ET. Interested participants can access the live webcast through Chemed's investor relations website. Chemed operates two subsidiaries: VITAS Healthcare, the largest provider of hospice care, and Roto-Rooter, the leading plumbing service provider in the U.S.
Chemed Corporation (NYSE:CHE) has declared a quarterly cash dividend of 38-cents per share, marking a 5.6% increase from the 36-cent dividend paid in June 2022. This dividend will be payable on September 2, 2022, to shareholders of record as of August 15, 2022. This is the 205th consecutive quarterly dividend paid by Chemed since it became public 51 years ago. The company operates two subsidiaries: VITAS Healthcare and Roto-Rooter.
Chemed Corporation (NYSE: CHE) reported its financial results for Q2 2022, revealing a 0.2% decline in revenue to $531 million. GAAP diluted EPS increased 25.4% to $4.40. The VITAS segment faced challenges, with net patient revenue down 4.5% to $298 million and a 10.4% decrease in net income. In contrast, Roto-Rooter demonstrated growth with revenue up 6.0% to $233 million and an 8.8% rise in net income. Chemed's cash position stood at $9.6 million with $117 million in debt, while share repurchases remain a priority as approximately $125 million is left for buybacks.
Chemed Corporation (NYSE: CHE) will release its financial results for the second quarter ending June 30, 2022, on Wednesday, July 27, 2022, after market close. A conference call and webcast to discuss these results will take place on Thursday, July 28, 2022, at 10 a.m. ET. The call can be accessed through Chemed’s investor relations website, and a replay will be available two hours post-call. Chemed operates VITAS Healthcare, the largest provider of hospice care, and Roto-Rooter, a leading plumbing service.